仁和药业
(000650)
| 流通市值：90.00亿 | | | 总市值：94.64亿 |
| 流通股本：13.31亿 | | | 总股本：14.00亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,818,691,932.62 | 2,681,918,127.26 | 1,355,800,163.83 | 5,153,215,069.28 |
| 营业收入 | 3,818,691,932.62 | 2,681,918,127.26 | 1,355,800,163.83 | 5,153,215,069.28 |
| 二、营业总成本 | 3,064,885,731.35 | 2,174,425,762.11 | 1,073,777,666.12 | 4,208,236,704.62 |
| 营业成本 | 2,368,282,881.11 | 1,665,673,372.5 | 821,517,065.99 | 3,266,276,548.18 |
| 税金及附加 | 36,232,563.78 | 24,990,567.89 | 13,538,659.5 | 44,405,497.04 |
| 销售费用 | 416,203,819.41 | 308,399,122.65 | 146,163,607.41 | 558,578,853.92 |
| 管理费用 | 232,847,562.6 | 165,361,310.44 | 91,783,240.8 | 311,503,703.11 |
| 研发费用 | 29,412,725.43 | 21,857,983.63 | 7,684,761.3 | 50,536,984.73 |
| 财务费用 | -18,093,820.98 | -11,856,595 | -6,909,668.88 | -23,064,882.36 |
| 其中:利息费用 | 281,868.1 | 203,179.03 | 109,176.69 | 427,600.16 |
| 其中:利息收入 | 21,159,389.1 | 14,354,400.94 | 7,078,748.04 | 24,180,981.14 |
| 加:公允价值变动收益 | -270,682.21 | 1,713,694.79 | 654,757.69 | 22,114,523.49 |
| 加:投资收益 | 53,916,745.04 | 13,500,083.9 | 8,324,881.74 | 46,313,665.43 |
| 资产处置收益 | 29,490.05 | 11,045.28 | 0 | 337,209.2 |
| 资产减值损失(新) | 0 | 0 | 91,690.49 | -68,739,396.98 |
| 信用减值损失(新) | -1,652,834.78 | -1,647,314.25 | 79,256.14 | -6,674,751.59 |
| 其他收益 | 53,467,082.77 | 41,144,996.75 | 4,878,757.19 | 14,933,657.08 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 859,296,002.14 | 562,214,871.62 | 296,051,840.96 | 953,263,271.29 |
| 加:营业外收入 | 2,142,555.94 | 1,299,318.55 | 799,450.11 | 5,536,798.7 |
| 减:营业外支出 | 2,704,304.03 | 2,376,067.02 | 1,709,371.57 | 5,260,212.02 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 858,734,254.05 | 561,138,123.15 | 295,141,919.5 | 953,539,857.97 |
| 减:所得税费用 | 206,140,556.77 | 132,876,271.74 | 75,847,801.25 | 241,982,940.93 |
| 六、净利润 | 652,593,697.28 | 428,261,851.41 | 219,294,118.25 | 711,556,917.04 |
| 持续经营净利润 | 652,593,697.28 | 428,261,851.41 | 219,294,118.25 | 711,556,917.04 |
| 归属于母公司股东的净利润 | 540,375,630.58 | 356,548,925.17 | 182,299,215.54 | 574,441,773.76 |
| 少数股东损益 | 112,218,066.7 | 71,712,926.24 | 36,994,902.71 | 137,115,143.28 |
| (一)基本每股收益 | 0.39 | 0.25 | 0.13 | 0.41 |
| (二)稀释每股收益 | 0.39 | 0.25 | 0.13 | 0.41 |
| 九、综合收益总额 | 652,593,697.28 | 428,261,851.41 | 219,294,118.25 | 711,556,917.04 |
| 归属于母公司股东的综合收益总额 | 540,375,630.58 | 356,548,925.17 | 182,299,215.54 | 574,441,773.76 |
| 归属于少数股东的综合收益总额 | 112,218,066.7 | 71,712,926.24 | 36,994,902.71 | 137,115,143.28 |
| 公告日期 | 2023-10-30 | 2023-08-25 | 2023-04-28 | 2023-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |